General Information of the Compound
Compound ID
CP0382970
Compound Name
4-(6-piperidin-1-yl-7H-purin-2-yl)phenol
    Show/Hide
Structure
Formula
C16H17N5O
Molecular Weight
295.346
Canonical SMILES
Oc1ccc(cc1)-c1nc(N2CCCCC2)c2nc[nH]c2n1
    Show/Hide
InChI
InChI=1S/C16H17N5O/c22-12-6-4-11(5-7-12)14-19-15-13(17-10-18-15)16(20-14)21-8-2-1-3-9-21/h4-7,10,22H,1-3,8-9H2,(H,17,18,19,20)
    Show/Hide
InChIKey
MXYYZWVYIXOVIS-UHFFFAOYSA-N
Physicochemical Property
logP
2.7158
Rotatable Bonds
2
Heavy Atom Count
22
Polar Areas
77.93
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 155525396
ChEMBL ID
CHEMBL4457537
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00840, Adenosine receptor A1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000939 CHO-A1 Cricetulus griseus (Chinese hamster)  1
1
Ki = 10 nM
   TI
   LI
   LO
   TS
Protein ID: PT00862, Adenosine receptor A2a
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL001005 HeLa-A2A Homo sapiens (Human)  1
1
Ki = 100 nM
   TI
   LI
   LO
   TS
Protein ID: PT01278, Adenosine receptor A2b
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000955 HEK-293-A2B Homo sapiens (Human)  1
1
Ki = 79.43 nM
   TI
   LI
   LO
   TS
Protein ID: PT01279, Adenosine receptor A3
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL001006 HeLa-A3 Homo sapiens (Human)  1
1
Ki = 39.81 nM
   TI
   LI
   LO
   TS